A Plus Biotechnology Co., Ltd. (TPE:6918)

Market Cap	2.39B -32.6%
Revenue (ttm)	858.89M +9.0%
Net Income	173.26M +9.1%
EPS	5.12 -1.7%
Shares Out	34.07M
PE Ratio	13.69
Forward PE	n/a
Dividend	5.00 (6.97%)
Ex-Dividend Date	Mar 27, 2026

Volume	46,547
Open	70.60
Previous Close	70.10
Day's Range	68.60 - 70.60
52-Week Range	68.30 - 103.50
Beta	0.06
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 12, 2026

About A Plus Biotechnology

A Plus Biotechnology Co., Ltd. engages in the manufacturing and wholesale of orthopedic and other medical devices. The company offers products for chest, shoulder, spine, elbow, wrist and hand, pelvic and hip, knee, foot and ankle, osteotomy, pediatric and ESF, biologics. It also provides bone grafts. A Plus Biotechnology Co., Ltd. was founded in 2009 and is based in New Taipei City, Taiwan.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6918

Financial Performance

In 2025, A Plus Biotechnology's revenue was 835.89 million, an increase of 8.61% compared to the previous year's 769.59 million. Earnings were 169.38 million, an increase of 12.13%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 30, 2026

Data Sources Report a data error